AMY BARNETT: Open Payments
NPI 1114542560 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,500 in 80 payments from 19 companies in 2025. Trend: 2023 $1,272 · 2024 $1,477 · 2025 $1,500
Food & beverage: $1,501
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $247 |
| AstraZeneca Pharmaceuticals LP | 6 | $232 |
| Axsome Therapeutics, Inc. | 5 | $98 |
| Exact Sciences Corporation | 5 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Lilly USA, LLC | 5 | $90 |
| Vanda Pharmaceuticals Inc. | 3 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Novo Nordisk Inc | 5 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $85 |
Products named: AIRSUPRA, VRAYLAR, Auvelity, CAPLYTA, FANAPT, REXULTI, Cologuard Collection Kit, QULIPTA.
Industry payments across AL — which companies pay providers there.
